CI
Cigna Corporation NYSE Listed Mar 31, 1982$281.03
-1.42%
vs $285.09
Mkt Cap $74.3B
52w Low $239.51
41.8% of range
52w High $338.89
50d MA $283.71
200d MA $281.52
P/E (TTM)
12.9x
EV/EBITDA
8.5x
P/B
1.8x
Debt/Equity
0.8x
ROE
14.3%
P/FCF
8.9x
RSI (14)
50.70
ATR (14)
$6.36
Beta
0.27
50d MA
$283.71
200d MA
$281.52
Avg Volume
1.6M
The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
900 Cottage Grove Road · Bloomfield, CT 06002 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | TNS | 7.60 | 7.79 | +2.5% | 290.58 | -0.5% | -2.6% | -1.3% | -1.3% | +2.3% | +0.7% | — |
| Feb 5, 2026 | TNS | 7.88 | 8.08 | +2.5% | 284.53 | -0.3% | +2.6% | +0.8% | -2.2% | +2.4% | -2.4% | — |
| Oct 30, 2025 | TNS | 7.64 | 7.83 | +2.5% | 247.10 | +0.4% | -1.1% | +5.8% | +2.3% | -1.9% | -1.2% | — |
| Jul 31, 2025 | TNS | 7.16 | 7.20 | +0.6% | 267.38 | +0.8% | -1.9% | +1.7% | +1.6% | -0.3% | +0.4% | — |
| May 2, 2025 | TNS | 6.35 | 6.74 | +6.1% | 334.75 | +0.7% | -0.5% | +0.2% | +0.2% | -0.4% | +0.1% | — |
| Jan 30, 2025 | TNS | 7.84 | 6.64 | -15.3% | 282.98 | +0.6% | +4.0% | -0.6% | -0.3% | +0.6% | -2.1% | — |
| Oct 31, 2024 | TNS | 7.23 | 7.51 | +3.9% | 314.81 | -0.5% | +0.5% | -1.3% | +1.9% | -1.0% | +1.4% | — |
| Aug 1, 2024 | TNS | 6.41 | 6.72 | +4.8% | 332.60 | +0.2% | +1.4% | -3.4% | +1.1% | -0.1% | +1.8% | — |
| May 2, 2024 | TNS | 6.22 | 6.47 | +4.0% | 344.50 | -0.6% | -0.9% | +0.3% | +1.3% | +0.2% | +1.0% | — |
| Feb 2, 2024 | TNS | 6.54 | 6.79 | +3.8% | 323.84 | +1.1% | -0.8% | +2.0% | +0.9% | +0.5% | +0.8% | — |
| Nov 2, 2023 | TNS | 6.66 | 6.77 | +1.7% | 318.89 | -0.4% | -2.6% | -1.2% | -3.8% | +0.1% | -2.2% | — |
| Aug 3, 2023 | TNS | 6.02 | 6.13 | +1.8% | 287.64 | +0.0% | -0.4% | +1.8% | +0.1% | -1.3% | +0.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 26 | Barclays | Downgrade | Overweight → Equal Weight | $304 | $286.24 | $283.00 | -1.1% | -1.9% | +1.8% | -0.5% | -2.4% | -1.2% |
| May 20 | Deutsche Bank | Downgrade | Buy → Hold | $302 | $291.28 | $291.27 | -0.0% | -2.8% | -0.4% | +1.5% | -1.9% | +1.8% |
| May 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $290.58 | $289.08 | -0.5% | -2.6% | -1.3% | -1.3% | +2.3% | +0.7% |
| May 1 | RBC Capital | Maintains | Outperform → Outperform | — | $290.58 | $289.08 | -0.5% | -2.6% | -1.3% | -1.3% | +2.3% | +0.7% |
| May 1 | Barclays | Maintains | Overweight → Overweight | — | $290.58 | $289.08 | -0.5% | -2.6% | -1.3% | -1.3% | +2.3% | +0.7% |
| May 1 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $290.58 | $289.08 | -0.5% | -2.6% | -1.3% | -1.3% | +2.3% | +0.7% |
| Apr 20 | Jefferies | Maintains | Buy → Buy | — | $278.64 | $279.78 | +0.4% | +0.5% | -1.2% | -0.7% | +1.8% | -1.5% |
| Mar 12 | Bernstein | Upgrade | Market Perform → Outperform | — | $260.87 | $263.28 | +0.9% | +1.9% | +0.5% | +0.4% | -1.8% | +0.4% |
| Mar 3 | Piper Sandler | Maintains | Overweight → Overweight | — | $290.85 | $283.00 | -2.7% | -2.4% | +0.3% | -1.2% | -3.4% | -0.7% |
| Feb 17 | Truist | Maintains | Buy → Buy | — | $291.44 | $294.43 | +1.0% | -0.3% | -0.2% | -1.4% | -2.0% | +1.0% |
| Feb 9 | TD Cowen | Maintains | Buy → Buy | — | $292.05 | $295.00 | +1.0% | +0.8% | -2.2% | +2.4% | -2.4% | +1.3% |
| Feb 6 | Barclays | Maintains | Overweight → Overweight | — | $284.53 | $283.72 | -0.3% | +2.6% | +0.8% | -2.2% | +2.4% | -2.4% |
| Feb 6 | RBC Capital | Maintains | Outperform → Outperform | — | $284.53 | $283.72 | -0.3% | +2.6% | +0.8% | -2.2% | +2.4% | -2.4% |
| Feb 6 | Guggenheim | Maintains | Buy → Buy | — | $284.53 | $283.72 | -0.3% | +2.6% | +0.8% | -2.2% | +2.4% | -2.4% |
| Feb 2 | Guggenheim | Maintains | Buy → Buy | — | $274.11 | $272.09 | -0.7% | -0.9% | +1.4% | -1.3% | +4.7% | +2.6% |
| Jan 5 | Truist | Maintains | Buy → Buy | — | $279.12 | $277.62 | -0.5% | +1.7% | +0.3% | -2.0% | +1.7% | -1.7% |
| Jan 5 | Barclays | Maintains | Overweight → Overweight | — | $279.12 | $277.62 | -0.5% | +1.7% | +0.3% | -2.0% | +1.7% | -1.7% |
| Nov 12 | Bernstein | Maintains | Market Perform → Market Perform | — | $268.00 | $266.50 | -0.6% | +1.0% | +0.1% | -0.5% | +0.6% | +0.5% |
| Nov 5 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $264.66 | $261.46 | -1.2% | -1.9% | -1.2% | +3.2% | -2.4% | +3.8% |
| Nov 4 | Goldman Sachs | Maintains | Buy → Buy | — | $258.62 | $257.70 | -0.4% | +2.3% | -1.9% | -1.2% | +3.2% | -2.4% |
| Nov 4 | TD Cowen | Maintains | Buy → Buy | — | $258.62 | $257.70 | -0.4% | +2.3% | -1.9% | -1.2% | +3.2% | -2.4% |
| Nov 4 | JP Morgan | Maintains | Overweight → Overweight | — | $258.62 | $257.70 | -0.4% | +2.3% | -1.9% | -1.2% | +3.2% | -2.4% |
| Nov 3 | Barclays | Maintains | Overweight → Overweight | — | $244.41 | $242.74 | -0.7% | +5.8% | +2.3% | -1.9% | -1.2% | +3.2% |
| Sep 4 | Barclays | Maintains | Overweight → Overweight | — | $300.48 | $299.26 | -0.4% | +1.2% | +0.4% | -1.4% | +0.4% | +0.1% |
| Aug 26 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $300.76 | $300.14 | -0.2% | -0.1% | -0.1% | -0.3% | +0.6% | -0.0% |
| Aug 14 | Baird | Maintains | Outperform → Outperform | — | $287.10 | $281.36 | -2.0% | +1.1% | +2.2% | +0.5% | +1.3% | +0.8% |
| Aug 14 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $287.10 | $281.36 | -2.0% | +1.1% | +2.2% | +0.5% | +1.3% | +0.8% |
| Aug 4 | Guggenheim | Maintains | Buy → Buy | — | $262.23 | $262.22 | -0.0% | +1.7% | +1.6% | -0.3% | +0.4% | +1.4% |
| Aug 1 | Barclays | Maintains | Overweight → Overweight | — | $267.38 | $269.49 | +0.8% | -1.9% | +1.7% | +1.6% | -0.3% | +0.4% |
| Jun 26 | RBC Capital | Maintains | Outperform → Outperform | — | $316.00 | $317.61 | +0.5% | +4.4% | -1.1% | +1.3% | +1.2% | -4.2% |
| Jun 3 | RBC Capital | Maintains | Outperform → Outperform | — | $314.99 | $312.31 | -0.9% | -1.1% | -0.5% | +0.3% | +0.4% | -0.2% |
| Jun 2 | Barclays | Maintains | Overweight → Overweight | — | $316.64 | $315.60 | -0.3% | -0.5% | -1.1% | -0.5% | +0.3% | +0.4% |
| May 23 | Guggenheim | Maintains | Buy → Buy | — | $312.68 | $314.20 | +0.5% | +1.1% | -0.2% | -1.4% | +0.4% | +1.5% |
| May 12 | Truist | Maintains | Buy → Buy | — | $333.46 | $324.08 | -2.8% | -5.3% | -4.4% | +0.5% | +1.8% | +3.9% |
| May 6 | Guggenheim | Maintains | Buy → Buy | — | $333.01 | $332.88 | -0.0% | +0.2% | +0.2% | -0.4% | +0.1% | -5.3% |
| May 5 | Barclays | Maintains | Overweight → Overweight | — | $334.75 | $337.01 | +0.7% | -0.5% | +0.2% | +0.2% | -0.4% | +0.1% |
| May 5 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $334.75 | $337.01 | +0.7% | -0.5% | +0.2% | +0.2% | -0.4% | +0.1% |
| May 5 | Morgan Stanley | Maintains | Overweight → Overweight | — | $334.75 | $337.01 | +0.7% | -0.5% | +0.2% | +0.2% | -0.4% | +0.1% |
| May 5 | Piper Sandler | Maintains | Overweight → Overweight | — | $334.75 | $337.01 | +0.7% | -0.5% | +0.2% | +0.2% | -0.4% | +0.1% |
| May 5 | Guggenheim | Maintains | Buy → Buy | — | $334.75 | $337.01 | +0.7% | -0.5% | +0.2% | +0.2% | -0.4% | +0.1% |
| Apr 15 | Baird | Maintains | Outperform → Outperform | — | $329.20 | $329.97 | +0.2% | -0.2% | +0.2% | +0.2% | -1.6% | +3.8% |
| Apr 11 | Truist | Maintains | Buy → Buy | — | $327.27 | $323.73 | -1.1% | +0.9% | -0.3% | -0.2% | +0.2% | +0.2% |
| Apr 9 | Mizuho | Maintains | Outperform → Outperform | — | $313.84 | $311.79 | -0.7% | +2.0% | +2.3% | +0.9% | -0.3% | -0.2% |
| Mar 20 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $320.83 | $321.00 | +0.1% | +0.2% | -1.5% | +1.2% | -1.1% | +1.4% |
| Feb 4 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $292.46 | $289.32 | -1.1% | -0.3% | +0.6% | -2.1% | -0.2% | +2.1% |
| Feb 4 | Truist | Maintains | Buy → Buy | — | $292.46 | $289.32 | -1.1% | -0.3% | +0.6% | -2.1% | -0.2% | +2.1% |
| Feb 3 | UBS | Maintains | Buy → Buy | — | $294.21 | $292.12 | -0.7% | -0.6% | -0.3% | +0.6% | -2.1% | -0.2% |
| Feb 3 | Piper Sandler | Maintains | Overweight → Overweight | — | $294.21 | $292.12 | -0.7% | -0.6% | -0.3% | +0.6% | -2.1% | -0.2% |
| Jan 31 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $282.98 | $284.71 | +0.6% | +4.0% | -0.6% | -0.3% | +0.6% | -2.1% |
| Jan 31 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $282.98 | $284.71 | +0.6% | +4.0% | -0.6% | -0.3% | +0.6% | -2.1% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Kates Jamie GOff | Chief Accounting Officer | Sell | 899 | $298.61 | $268K | 2,368 | -2.33% | — |
| May 12, 2026 | Cordani DavidDir/Off | Chairman & CEO | Sell | 2,231 | $298.53 | $666K | 34,337 | -3.28% | -0.38% |
| May 12, 2026 | Cordani DavidDir/Off | Chairman & CEO | Sell | 15,319 | $298.24 | $4.6M | 36,568 | -3.28% | -0.38% |
| May 12, 2026 | Cordani DavidDir/Off | Chairman & CEO | Sell | 2,017 | $296.84 | $599K | 51,887 | -3.28% | -0.38% |
| May 12, 2026 | Cordani DavidDir/Off | Chairman & CEO | Sell | 34,641 | $295.98 | $10.3M | 53,904 | -3.28% | -0.38% |
| May 12, 2026 | Cordani DavidDir/Off | Chairman & CEO | Sell | 38,487 | $294.98 | $11.4M | 88,545 | -3.28% | -0.38% |
| May 12, 2026 | Cordani DavidDir/Off | Chairman & CEO | Sell | 2,142 | $293.92 | $630K | 127,032 | -3.28% | -0.38% |
| May 12, 2026 | Cordani DavidDir/Off | Chairman & CEO | Sell | 7,861 | $292.88 | $2.3M | 129,174 | -3.28% | -0.38% |
| May 12, 2026 | Cordani DavidDir/Off | Chairman & CEO | Sell | 12,315 | $291.95 | $3.6M | 137,035 | -3.28% | -0.38% |
| May 12, 2026 | Cordani DavidDir/Off | Chairman & CEO | Sell | 13,732 | $291.01 | $4.0M | 149,350 | -3.28% | -0.38% |
| May 12, 2026 | Cordani DavidDir/Off | Chairman & CEO | Sell | 41,099 | $290.00 | $11.9M | 163,082 | -3.28% | -0.38% |
| May 12, 2026 | Cordani DavidDir/Off | Chairman & CEO | Sell | 13,839 | $288.85 | $4.0M | 204,181 | -3.28% | -0.38% |
| May 12, 2026 | Cordani DavidDir/Off | Chairman & CEO | Sell | 14,292 | $287.96 | $4.1M | 218,020 | -3.28% | -0.38% |
| May 12, 2026 | Cordani DavidDir/Off | Chairman & CEO | Sell | 3,903 | $286.83 | $1.1M | 232,312 | -3.28% | -0.38% |
8-K · 7.01
! Medium
Cigna Corporation -- 8-K 7.01: Regulation FD Disclosure
Cigna reaffirmed its 2026 guidance of at least $30.35 adjusted earnings per share, maintaining investor confidence in the company's profitability outlook during recent management meetings.
May 13
8-K
Cigna Corporation -- 8-K Filing
Cigna's leadership emphasizes strategic focus on healthcare innovation and digital transformation to enhance customer experience and operational efficiency across its insurance portfolio.
Apr 30
8-K
The Cigna Group -- 8-K Filing
Cigna Group shareholders will vote on an advisory measure regarding executive compensation practices, a non-binding referendum on management's pay structure.
Apr 27
8-K · 5.02
!!! Very High
The Cigna Group -- 8-K 5.02: Executive Change
Cigna Group appoints Brian C. Evanko as Chief Executive Officer effective July 1, 2026, signaling planned leadership transition and potential strategic direction change for the healthcare company.
Mar 3
8-K · 7.01
! Medium
The Cigna Group -- 8-K 7.01: Regulation FD Disclosure
Cigna Group reaffirmed its 2026 guidance of at least $30.25 adjusted earnings per share, signaling management confidence in achieving previously communicated financial targets.
Feb 27
8-K
The Cigna Group -- 8-K Filing
Cigna Group's 2025 initiatives focusing on expanded access, cost reduction, and transparency demonstrate management's commitment to improving customer value and operational efficiency.
Feb 5
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 17,122,069 | $4.6B | New | Mar 2026 |
| 2 | Dodge & Cox | 11,555,787 | $3.1B | Added | Mar 2026 |
| 3 | Fmr Llc | 10,957,272 | $2.9B | Reduced | Mar 2026 |
| 4 | Sanders Capital, Llc | 10,290,382 | $2.7B | Added | Mar 2026 |
| 5 | Morgan Stanley | 6,775,720 | $1.9B | Reduced | Dec 2025 |
| 6 | Vanguard Portfolio Management Llc | 6,163,438 | $1.6B | New | Mar 2026 |
| 7 | Gqg Partners Llc | 6,002,448 | $1.6B | Reduced | Mar 2026 |
| 8 | Jpmorgan Chase & Co | 5,805,639 | $1.5B | Added | Mar 2026 |
| 9 | Bank Of America Corp /de/ | 3,182,083 | $849M | Added | Mar 2026 |
| 10 | Arrowstreet Capital, Limited Partnership | 2,860,289 | $763M | Reduced | Mar 2026 |
| 11 | Northern Trust Corp | 2,702,601 | $721M | Reduced | Mar 2026 |
| 12 | Grantham, Mayo, Van Otterloo & Co. Llc | 2,598,218 | $693M | Added | Mar 2026 |
| 13 | Aqr Capital Management Llc | 2,587,106 | $672M | Added | Mar 2026 |
| 14 | Invesco Ltd. | 2,493,374 | $665M | Added | Mar 2026 |
| 15 | Nuveen, Llc | 1,847,126 | $493M | Reduced | Mar 2026 |
| 16 | Boston Partners | 1,777,664 | $474M | Added | Mar 2026 |
| 17 | Bank Of New York Mellon Corp | 1,688,636 | $450M | Added | Mar 2026 |
| 18 | Amundi | 1,550,003 | $413M | New | Mar 2026 |
| 19 | Capital Research Global Investors | 1,321,396 | $352M | Reduced | Mar 2026 |
| 20 | Capital World Investors | 1,301,221 | $347M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$74.34B
Enterprise Value
$99.01B
P/E (TTM)
12.86x
Forward P/E
9.27x
PEG Ratio
0.15x
P/B
1.78x
P/S
0.27x
P/FCF
8.91x
EV/EBITDA
8.53x
Shares Out
265.9M
Financials (TTM)
Revenue
$274.95B
Net Income
$5.96B
EBITDA
$11.61B
Free Cash Flow
$8.39B
Op Cash Flow
$9.60B
EPS Basic
$22.30
EPS Diluted
$22.17
EPS Forward
$30.32
Gross Margin
9.4%
Op Margin
3.3%
Net Margin
2.2%
Balance Sheet
Total Assets
$157.92B
Total Liab.
$116.05B
Total Equity
$41.87B
Cash
$7.68B
LT Debt
$30.87B
Book Value/Sh
$157.45
Debt/Equity
0.75x
Current Ratio
0.85
Quick Ratio
0.72
Returns & Growth
ROE
14.3%
ROA
3.8%
ROIC
7.3%
Rev Growth YoY
+11.3%
EPS Growth YoY
+82.0%
Price Returns
2W
-5.9%
1M
-4.5%
3M
-4.3%
6M
+0.0%
12M
-12.4%
Technicals
52W High
$338.89
52W Low
$239.51
50d MA
$283.71
200d MA
$281.52
RSI (14)
50.70
ATR (14)
$6.36
Beta
0.27
Avg Volume
1.6M
Dividends
Div Rate
$6.06
Div Yield
2.1%
Frequency
4
Ex-Div Date
Jun 4, 2026
Analyst Price Targets
Consensus
$327.50
High
$375.00
Low
$300.00
Median
$327.50
Data updated apr 25, 2026 1:21am
· Source: financialmodelingprep.com